Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Pliant Therapeutics, Inc. (PLRX) had Free Cash Flow per Share of $-0.80 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-56.17M |
|
-- |
|
-- |
|
$58.94M |
|
$-58.94M |
|
$2.77M |
|
$-56.17M |
|
$-56.17M |
|
$-56.17M |
|
$-56.17M |
|
$-56.17M |
|
$-56.17M |
|
$-58.94M |
|
$-57.12M |
|
61.22M |
|
61.22M |
|
$-0.92 |
|
$-0.92 |
|
| Balance Sheet Financials | |
$311.19M |
|
$5.24M |
|
$33.58M |
|
$344.77M |
|
$28.20M |
|
-- |
|
$59.40M |
|
$87.61M |
|
$257.16M |
|
$257.16M |
|
$257.16M |
|
61.39M |
|
| Cash Flow Statement Financials | |
$-48.86M |
|
$69.11M |
|
$0.50M |
|
$72.67M |
|
$93.42M |
|
$20.75M |
|
$8.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.84% |
|
-21.84% |
|
-16.29% |
|
-21.84% |
|
$4.19 |
|
|
Free Cash Flow per Share |
$-0.80 |
$-0.80 |
|